BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 819682)

  • 1. [Quantitation of the urinary L-chain multiple myeloma (author's transl)].
    Tominaga K
    Rinsho Byori; 1976 Apr; 24(4):294. PubMed ID: 819682
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of free kappa and lambda light chains in urine by immunoenzyme analysis].
    León VJ; León E; Martínez-Pescador R; López-Borrasca A
    Sangre (Barc); 1986; 31(3):311-6. PubMed ID: 3092374
    [No Abstract]   [Full Text] [Related]  

  • 3. [Analysis of monoclonal protein in 72 cases of multiple myeloma].
    Yang JJ; Zhang GS; Chen XR
    Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):152-4. PubMed ID: 12536652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Two cases of IgD (K-type) myeloma--with special reference to urine protein analyses (author's transl)].
    Nakazawa O; Niitsu Y; Katayama S; Koyama R; Gocho Y
    Rinsho Ketsueki; 1975 Oct; 16(10):963-71. PubMed ID: 813021
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence and monitoring of oligosecretory myeloma.
    Larson D; Kyle RA; Rajkumar SV
    N Engl J Med; 2012 Aug; 367(6):580-1. PubMed ID: 22873553
    [No Abstract]   [Full Text] [Related]  

  • 6. [Non-amyloid nephrotic syndrome: first isolated manifestation of a kappa light chain myeloma (author's transl)].
    Mignon F; Vasmant D; Richet G; Wang A; Morel-Maroger L; Brouet JC
    Ann Med Interne (Paris); 1979; 130(11):513-6. PubMed ID: 121516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [IgD myeloma. Considerations about its diagnosis based on three cases (author's transl)].
    López-Aldeguer J; Redón J; González-Molina J; Benedito M; Herranz C; Lacruz J; Navarro JR; Caballero M
    Sangre (Barc); 1981; 26(6):1139-44. PubMed ID: 6805083
    [No Abstract]   [Full Text] [Related]  

  • 8. [Free immunoglobulin L chains].
    Numata Y
    Rinsho Byori; 1983 May; 31(5):489-95. PubMed ID: 6415322
    [No Abstract]   [Full Text] [Related]  

  • 9. [Multiple myeloma--comment on the contribution in DMW 6/2005].
    Herzog W
    Dtsch Med Wochenschr; 2005 Sep; 130(39):2228. PubMed ID: 16189763
    [No Abstract]   [Full Text] [Related]  

  • 10. [Characterization of L chains in myelomatous human urine. Physicochemical and immunological study].
    Rascovsky S; Scavini LM; Sanchez de la Vega W
    Medicina (B Aires); 1973; 33(2):117-22. PubMed ID: 4198263
    [No Abstract]   [Full Text] [Related]  

  • 11. [Purification of the Bence Jones protein from patients with myeloma].
    Chaker R; Siala T
    Arch Inst Pasteur Tunis; 1982 Mar; 59(1):213-6. PubMed ID: 6817722
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunoglobulin light chain nephropathies.
    Sturgill BC; Tucker FL; Bolton WK
    Pathol Annu; 1987; 22 Pt 2():133-50. PubMed ID: 3120137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unusual case of IgE myeloma.
    Zavázal V; Sach J; Rozprimová L; Brumelová V
    Allergol Immunopathol (Madr); 1978; 6(5):423-6. PubMed ID: 742573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum free light chain measurements to reduce 24-h urine monitoring in patients with multiple myeloma with measurable urine monoclonal protein.
    Tschautscher M; Rajkumar V; Dispenzieri A; Lacy M; Gertz M; Buadi F; Dingli D; Hwa L; Fonder A; Hobbs M; Hayman S; Zeldenrust S; Lust J; Russell S; Leung N; Kapoor P; Go R; Lin Y; Gonsalves W; Kourelis T; Warsame R; Kyle R; Kumar S
    Am J Hematol; 2018 Oct; 93(10):1207-1210. PubMed ID: 30016549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic findings in multiple myeloma (author's transl)].
    Osorio G; Daiber A; Pinto R; Con I; Donoso A; Liendo F; Anguita T; Pinto O; Miranda E
    Rev Med Chil; 1976 Dec; 104(12):904-12. PubMed ID: 828755
    [No Abstract]   [Full Text] [Related]  

  • 16. [IgG-lambda myeloma protein "nonreactive" with anti-IgG-Fab and anti-light chain antisera].
    Niiya K; Taguchi H; Yoshimoto S; Miyoshi I; Fujishita M; Yube T
    Rinsho Ketsueki; 1983 May; 24(5):588-93. PubMed ID: 6411950
    [No Abstract]   [Full Text] [Related]  

  • 17. [Renal disease in myeloma. Role of the tumor cell mass (author's transl)].
    San Miguel J; Batlle J; Alberca I; Moraleda JM; López Borrasca A
    Med Clin (Barc); 1981 Apr; 76(8):347-9. PubMed ID: 7253752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myeloma and immunoglobins (author's transl)].
    Ohtani H
    Rinsho Byori; 1976 Apr; 24(4):287-93. PubMed ID: 819681
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary free light chain analysis by the Freelite immunoassay: a preliminary study in multiple myeloma.
    Le Bricon T; Bengoufa D; Benlakehal M; Bousquet B; Erlich D
    Clin Biochem; 2002 Oct; 35(7):565-7. PubMed ID: 12493586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of immunofixation on serum in light-chain myeloma.
    Anand M; Singh S; Kumar R; Sharma OD
    Ann Clin Biochem; 2004 Nov; 41(Pt 6):501-2. PubMed ID: 15588445
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.